In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Mark J LevisMark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.ORCID 0000-0003-0473-6982 Mehdi HamadaniMark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.ORCID 0000-0001-5372-510X Mary M HorowitzMark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.ORCID 0000-0002-9502-785X Yi-Bin ChenMark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.ORCID 0000-0002-9554-1058 BMT CTN 1506 InvestigatorsMark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MBlood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MNCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID39083722
PMCPMC11540746
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390